Freedom251 › Autism Learning Apps
Buddy-In
Facts from Buddy-In's own pages
- Clinical evidence
- Neudive says exploratory and confirmatory clinical trials were completed and found safety and improvement in Adaptive Behavior Composite score versus control. · neudive.com, 14 Nov 2026
- Clinician monitoring
- The system records usage, performance, and training progress for clinicians to monitor in real time. · neudive.com, 14 Nov 2026
- Founded
- 2022 · neudive.com, 19 Oct 2026
- Headquarters
- Daegu, South Korea · neudive.com, 19 Oct 2026
- Maker
- Neudive says it was founded in 2022 and lists its headquarters in Daegu, South Korea. · neudive.com, 14 Nov 2026
- Medical-device certification
- Buddy-In received MFDS manufacturing certification as a Class II digital medical device on May 7, 2026. · neudive.com, 14 Nov 2026
- Parent reports
- Parents receive reports about what their child is learning and changes in social skills over time. · neudive.com, 14 Nov 2026
- Personalized scenarios
- Mobile scenario-based games and an algorithm-driven structure tailor training to each user's level. · neudive.com, 14 Nov 2026
- Prescription
- Buddy-In is prescribed by a medical professional following diagnosis and assessment of suitability. · neudive.com, 14 Nov 2026
- Purpose
- Buddy-In is a digital medical device for social-skills training for children and adolescents aged 10–18 with ASD or Social (Pragmatic) Communication Disorder. · neudive.com, 14 Nov 2026
- Support
- Neudive lists weekday support hours of 09:00–18:00 and provides a phone number and email address. · neudive.com, 14 Nov 2026
- Therapy approach
- Buddy-In is based on Cognitive Behavioral Therapy and Social Skills Training. · neudive.com, 14 Nov 2026
- Training schedule
- The program is designed for 30 sessions over six weeks, five times a week, for about 10 minutes per session. · neudive.com, 14 Nov 2026
- Use alongside treatment
- Buddy-In is intended to complement, not replace, existing treatment or in-person support. · neudive.com, 14 Nov 2026
- Use caution
- The maker recommends guardian monitoring and stopping use if discomfort or unusual behavior occurs. · neudive.com, 14 Nov 2026
Where Buddy-In stands on Freedom251
- Autism Learning Apps#20 of 30